Click here to get full coverage on Two new Vaxart directors urge support as group targets half the board - Stock Titan

Two new Vaxart directors urge support as group targets half the board  Stock Titan

Two new Vaxart directors urge support as group targets half the board - Stock Titan

Click here to get full coverage on Is Vaxart's (VXRT) Conference Spotlight Reframing the Oral Vaccine Story or Just Polishing It? - Yahoo Finance

Is Vaxart's (VXRT) Conference Spotlight Reframing the Oral Vaccine Story or Just Polishing It?  Yahoo Finance

Is Vaxart's (VXRT) Conference Spotlight Reframing the Oral Vaccine Story or Just Polishing It? - Yahoo Finance

Click here to get full coverage on Vaxart Inc (VXRT) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey

Vaxart Inc (VXRT) Dividends & Stock Splits: Historical Payouts and Event Timeline  TradingKey

Vaxart Inc (VXRT) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey

Click here to get full coverage on VAXART ($VXRT) Releases Q4 2025 Earnings | VXRT Stock News - Quiver Quantitative

VAXART ($VXRT) Releases Q4 2025 Earnings | VXRT Stock News  Quiver Quantitative

VAXART ($VXRT) Releases Q4 2025 Earnings | VXRT Stock News - Quiver Quantitative

Click here to get full coverage on Pills instead of shots? Vaxart showcases oral vaccines at BIO 2026 - Stock Titan

Pills instead of shots? Vaxart showcases oral vaccines at BIO 2026  Stock Titan

Pills instead of shots? Vaxart showcases oral vaccines at BIO 2026 - Stock Titan

Click here to get full coverage on Vaxart’s Two Newest Independent Directors James Breitmeyer, - GlobeNewswire

Vaxart’s Two Newest Independent Directors James Breitmeyer,  GlobeNewswire

Vaxart’s Two Newest Independent Directors James Breitmeyer, - GlobeNewswire

Click here to get full coverage on Vaxart Inc (VXRT) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey

Vaxart Inc (VXRT) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution  TradingKey

Vaxart Inc (VXRT) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey

Click here to get full coverage on Vaxart (VXRT) Valuation After New npj Vaccines Data On Oral Norovirus Candidate In Breastfeeding Women - Yahoo Finance

Vaxart (VXRT) Valuation After New npj Vaccines Data On Oral Norovirus Candidate In Breastfeeding Women  Yahoo Finance

Vaxart (VXRT) Valuation After New npj Vaccines Data On Oral Norovirus Candidate In Breastfeeding Women - Yahoo Finance

Click here to get full coverage on Biotech Vaxart faces shareholder board challenge as key vote nears - Stock Titan

Biotech Vaxart faces shareholder board challenge as key vote nears  Stock Titan

Biotech Vaxart faces shareholder board challenge as key vote nears - Stock Titan

Click here to get full coverage on Vaxart Inc (VXRT) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey

Vaxart Inc (VXRT) Shareholder Structure: Major Shareholders & Institutional Holdings  TradingKey

Vaxart Inc (VXRT) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey

Click here to get full coverage on Vaxart Inc (VXRT) Q3 2025 Earnings Call Highlights: Strategic Partnership and Revenue Surge ... - Yahoo Finance

Vaxart Inc (VXRT) Q3 2025 Earnings Call Highlights: Strategic Partnership and Revenue Surge ...  Yahoo Finance

Vaxart Inc (VXRT) Q3 2025 Earnings Call Highlights: Strategic Partnership and Revenue Surge ... - Yahoo Finance

Click here to get full coverage on Vaxart (VXRT) shareholders nominate three directors, press governance reforms - Stock Titan

Vaxart (VXRT) shareholders nominate three directors, press governance reforms  Stock Titan

Vaxart (VXRT) shareholders nominate three directors, press governance reforms - Stock Titan

Click here to get full coverage on Oral vaccine maker Vaxart faces board challenge from non-biotech nominees - Stock Titan

Oral vaccine maker Vaxart faces board challenge from non-biotech nominees  Stock Titan

Oral vaccine maker Vaxart faces board challenge from non-biotech nominees - Stock Titan

Click here to get full coverage on Vaxart targets Q2 data from 400-person oral COVID vaccine study - Stock Titan

Vaxart targets Q2 data from 400-person oral COVID vaccine study  Stock Titan

Vaxart targets Q2 data from 400-person oral COVID vaccine study - Stock Titan

Click here to get full coverage on Vaxart adds board member with 35 years in biotech, 8 FDA approvals - Stock Titan

Vaxart adds board member with 35 years in biotech, 8 FDA approvals  Stock Titan

Vaxart adds board member with 35 years in biotech, 8 FDA approvals - Stock Titan

Click here to get full coverage on Vaxart (NASDAQ: VXRT) CFO uses 31,395 shares to cover RSU taxes - Stock Titan

Vaxart (NASDAQ: VXRT) CFO uses 31,395 shares to cover RSU taxes  Stock Titan

Vaxart (NASDAQ: VXRT) CFO uses 31,395 shares to cover RSU taxes - Stock Titan

Click here to get full coverage on [DFAN14A] Vaxart, Inc. SEC Filing - Stock Titan

[DFAN14A] Vaxart, Inc. SEC Filing  Stock Titan

[DFAN14A] Vaxart, Inc. SEC Filing - Stock Titan

Click here to get full coverage on Vaxart, Inc. (VXRT) director adds 10,000 shares in open‑market buy - Stock Titan

Vaxart, Inc. (VXRT) director adds 10,000 shares in open‑market buy  Stock Titan

Vaxart, Inc. (VXRT) director adds 10,000 shares in open‑market buy - Stock Titan

Click here to get full coverage on Vaxart (NASDAQ: VXRT) CMO shares withheld to cover RSU tax obligations - Stock Titan

Vaxart (NASDAQ: VXRT) CMO shares withheld to cover RSU tax obligations  Stock Titan

Vaxart (NASDAQ: VXRT) CMO shares withheld to cover RSU tax obligations - Stock Titan

Click here to get full coverage on Vaxart Inc (VXRT) Institutional Confidence - TradingKey

Vaxart Inc (VXRT) Institutional Confidence  TradingKey

Vaxart Inc (VXRT) Institutional Confidence - TradingKey

Click here to get full coverage on Vaxart Inc (VXRT) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey

Vaxart Inc (VXRT) Earnings Forecast: Future EPS & Revenue Growth Estimates  TradingKey

Vaxart Inc (VXRT) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey

Click here to get full coverage on Vaxart (VXRT) CEO Steven Lo receives major stock option and RSU grants - Stock Titan

Vaxart (VXRT) CEO Steven Lo receives major stock option and RSU grants  Stock Titan

Vaxart (VXRT) CEO Steven Lo receives major stock option and RSU grants - Stock Titan

Click here to get full coverage on Vaxart opens May 8 stockholder Q&A after May 7 earnings release - Stock Titan

Vaxart opens May 8 stockholder Q&A after May 7 earnings release  Stock Titan

Vaxart opens May 8 stockholder Q&A after May 7 earnings release - Stock Titan

Click here to get full coverage on Vaxart Inc (VXRT) Financial Health: Profitability & Balance Sheet Analysis - TradingKey

Vaxart Inc (VXRT) Financial Health: Profitability & Balance Sheet Analysis  TradingKey

Vaxart Inc (VXRT) Financial Health: Profitability & Balance Sheet Analysis - TradingKey

Click here to get full coverage on Vaxart (OTCQX: VXRT) secures $25M discretionary equity line - Stock Titan

Vaxart (OTCQX: VXRT) secures $25M discretionary equity line  Stock Titan

Vaxart (OTCQX: VXRT) secures $25M discretionary equity line - Stock Titan

Click here to get full coverage on Vaxart Inc (VXRT) Valuation: PE, PB & Fair Value Analysis - TradingKey

Vaxart Inc (VXRT) Valuation: PE, PB & Fair Value Analysis  TradingKey

Vaxart Inc (VXRT) Valuation: PE, PB & Fair Value Analysis - TradingKey

Click here to get full coverage on Does Vaxart’s (VXRT) Early Norovirus Infant Data Hint At A Broader Oral Vaccine Platform Advantage? - simplywall.st

Does Vaxart’s (VXRT) Early Norovirus Infant Data Hint At A Broader Oral Vaccine Platform Advantage?  simplywall.st

Does Vaxart’s (VXRT) Early Norovirus Infant Data Hint At A Broader Oral Vaccine Platform Advantage? - simplywall.st

Click here to get full coverage on Vaxart Inc (VXRT) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey

Vaxart Inc (VXRT) Technical Analysis: Support, Resistance, Indicators & Moving Averages  TradingKey

Vaxart Inc (VXRT) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey

Click here to get full coverage on Assessing Vaxart (VXRT) Valuation As Conference Presentation Draws Increased Investor Attention - simplywall.st

Assessing Vaxart (VXRT) Valuation As Conference Presentation Draws Increased Investor Attention  simplywall.st

Assessing Vaxart (VXRT) Valuation As Conference Presentation Draws Increased Investor Attention - simplywall.st

Click here to get full coverage on Vaxart (VXRT) CSO Sean Tucker awarded 410K options and 200K shares - Stock Titan

Vaxart (VXRT) CSO Sean Tucker awarded 410K options and 200K shares  Stock Titan

Vaxart (VXRT) CSO Sean Tucker awarded 410K options and 200K shares - Stock Titan

Click here to get full coverage on Vaxart (VXRT) Revenue Surge To US$72.4 Million Tests Bearish Decline Narrative - simplywall.st

Vaxart (VXRT) Revenue Surge To US$72.4 Million Tests Bearish Decline Narrative  simplywall.st

Vaxart (VXRT) Revenue Surge To US$72.4 Million Tests Bearish Decline Narrative - simplywall.st

Click here to get full coverage on Vaxart Provides Business Update and Reports First Quarter 2026 Financial Results - GlobeNewswire

Vaxart Provides Business Update and Reports First Quarter 2026 Financial Results  GlobeNewswire

Vaxart Provides Business Update and Reports First Quarter 2026 Financial Results - GlobeNewswire

Click here to get full coverage on Vaxart Inc (VXRT) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey

Vaxart Inc (VXRT) Risk Assessment: Volatility, Financial Risk & Investment Risk  TradingKey

Vaxart Inc (VXRT) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey

Click here to get full coverage on Vaxart gains a 24-month funding option worth up to $25M - Stock Titan

Vaxart gains a 24-month funding option worth up to $25M  Stock Titan

Vaxart gains a 24-month funding option worth up to $25M - Stock Titan

Click here to get full coverage on Tax withholding trims Vaxart (NASDAQ: VXRT) SVP Sean Tucker RSU shares - Stock Titan

Tax withholding trims Vaxart (NASDAQ: VXRT) SVP Sean Tucker RSU shares  Stock Titan

Tax withholding trims Vaxart (NASDAQ: VXRT) SVP Sean Tucker RSU shares - Stock Titan

Click here to get full coverage on Vaxart opposes dissident slate as 5,400-patient COVID pill study runs - Stock Titan

Vaxart opposes dissident slate as 5,400-patient COVID pill study runs  Stock Titan

Vaxart opposes dissident slate as 5,400-patient COVID pill study runs - Stock Titan

Click here to get full coverage on Investors get 30-day replay of Vaxart talk at Oppenheimer conference - Stock Titan

Investors get 30-day replay of Vaxart talk at Oppenheimer conference  Stock Titan

Investors get 30-day replay of Vaxart talk at Oppenheimer conference - Stock Titan

Click here to get full coverage on Vaxart (OTCQX: VXRT) shifts from Harbor Way HQ to Utah Avenue space - Stock Titan

Vaxart (OTCQX: VXRT) shifts from Harbor Way HQ to Utah Avenue space  Stock Titan

Vaxart (OTCQX: VXRT) shifts from Harbor Way HQ to Utah Avenue space - Stock Titan

Click here to get full coverage on Vaxart Inc (VXRT) Q2 2025 Earnings Call Highlights: Revenue Surge Amidst Operational Challenges - Yahoo Finance

Vaxart Inc (VXRT) Q2 2025 Earnings Call Highlights: Revenue Surge Amidst Operational Challenges  Yahoo Finance

Vaxart Inc (VXRT) Q2 2025 Earnings Call Highlights: Revenue Surge Amidst Operational Challenges - Yahoo Finance

Click here to get full coverage on Vaxart Announces Share Purchase Agreement for up to $25 Million with Lincoln Park Capital - Yahoo Finance

Vaxart Announces Share Purchase Agreement for up to $25 Million with Lincoln Park Capital  Yahoo Finance

Vaxart Announces Share Purchase Agreement for up to $25 Million with Lincoln Park Capital - Yahoo Finance

Click here to get full coverage on Lobbying Update: $50,000 of VAXART INC. lobbying was just disclosed | VXRT Stock News - Quiver Quantitative

Lobbying Update: $50,000 of VAXART INC. lobbying was just disclosed | VXRT Stock News  Quiver Quantitative

Lobbying Update: $50,000 of VAXART INC. lobbying was just disclosed | VXRT Stock News - Quiver Quantitative

Click here to get full coverage on Vaxart (VXRT) Institutional Ownership 2026 $VXRT - MarketBeat

Vaxart (VXRT) Institutional Ownership 2026 $VXRT  MarketBeat

Vaxart (VXRT) Institutional Ownership 2026 $VXRT - MarketBeat

Click here to get full coverage on Q3 2025 Vaxart Inc Earnings Call Transcript - GuruFocus

Q3 2025 Vaxart Inc Earnings Call Transcript  GuruFocus

Q3 2025 Vaxart Inc Earnings Call Transcript - GuruFocus

Click here to get full coverage on Vaxart to Participate in BTIG Infectious Disease Day 2026 - GlobeNewswire

Vaxart to Participate in BTIG Infectious Disease Day 2026  GlobeNewswire

Vaxart to Participate in BTIG Infectious Disease Day 2026 - GlobeNewswire

Click here to get full coverage on The 3 Penny Stocks You Swore You’d Never Buy (But You’ll Check Anyway) - MarketBeat

The 3 Penny Stocks You Swore You’d Never Buy (But You’ll Check Anyway)  MarketBeat

The 3 Penny Stocks You Swore You’d Never Buy (But You’ll Check Anyway) - MarketBeat

Click here to get full coverage on Vaxart to Present at the Oppenheimer 36th Annual Healthcare Life Sciences Conference on February 25, 2026 - GlobeNewswire

Vaxart to Present at the Oppenheimer 36th Annual Healthcare Life Sciences Conference on February 25, 2026  GlobeNewswire

Vaxart to Present at the Oppenheimer 36th Annual Healthcare Life Sciences Conference on February 25, 2026 - GlobeNewswire

Click here to get full coverage on VXRT Stock Price and Chart — OTC:VXRT - TradingView

VXRT Stock Price and Chart — OTC:VXRT  TradingView

VXRT Stock Price and Chart — OTC:VXRT - TradingView

Click here to get full coverage on Vaxart faces proxy contest ahead of July annual meeting - Investing.com

Vaxart faces proxy contest ahead of July annual meeting  Investing.com

Vaxart faces proxy contest ahead of July annual meeting - Investing.com

Click here to get full coverage on Vaxart Publishes Positive Phase 1 Trial Results for Oral Norovirus Vaccine in Breastfeeding Women, Highlighting Passive Immunity Transfer to Infants - Quiver Quantitative

Vaxart Publishes Positive Phase 1 Trial Results for Oral Norovirus Vaccine in Breastfeeding Women, Highlighting Passive Immunity Transfer to Infants  Quiver Quantitative

Vaxart Publishes Positive Phase 1 Trial Results for Oral Norovirus Vaccine in Breastfeeding Women, Highlighting Passive Immunity Transfer to Infants - Quiver Quantitative

Click here to get full coverage on Vaxart files preliminary proxy, urges support for board as Phase 2b COVID readout, $61M cash runway into Q2 2027 - TradingView

Vaxart files preliminary proxy, urges support for board as Phase 2b COVID readout, $61M cash runway into Q2 2027  TradingView

Vaxart files preliminary proxy, urges support for board as Phase 2b COVID readout, $61M cash runway into Q2 2027 - TradingView

Click here to get full coverage on Vaxart Provides Business Update and Reports Third Quarter 2025 Financial Results - Yahoo Finance

Vaxart Provides Business Update and Reports Third Quarter 2025 Financial Results  Yahoo Finance

Vaxart Provides Business Update and Reports Third Quarter 2025 Financial Results - Yahoo Finance

Click here to get full coverage on 3 Stocks Under $5 With Strong Analyst Upside Potential - MarketBeat

3 Stocks Under $5 With Strong Analyst Upside Potential  MarketBeat

3 Stocks Under $5 With Strong Analyst Upside Potential - MarketBeat

Click here to get full coverage on VXRT: Oral pill vaccine platform advances with strong clinical data and extended financial runway - TradingView

VXRT: Oral pill vaccine platform advances with strong clinical data and extended financial runway  TradingView

VXRT: Oral pill vaccine platform advances with strong clinical data and extended financial runway - TradingView

Click here to get full coverage on Vax reports $237.3M revenue and $0.07 EPS on turnaround to $16.3M net income - TradingView

Vax reports $237.3M revenue and $0.07 EPS on turnaround to $16.3M net income  TradingView

Vax reports $237.3M revenue and $0.07 EPS on turnaround to $16.3M net income - TradingView

Click here to get full coverage on Vaxart Announces Withdrawal of Reverse Stock Split Proposal - Yahoo Finance

Vaxart Announces Withdrawal of Reverse Stock Split Proposal  Yahoo Finance

Vaxart Announces Withdrawal of Reverse Stock Split Proposal - Yahoo Finance

Click here to get full coverage on Vaxart director Mark Watson buys $6,530 in company stock - Investing.com

Vaxart director Mark Watson buys $6,530 in company stock  Investing.com

Vaxart director Mark Watson buys $6,530 in company stock - Investing.com

Click here to get full coverage on Best Stocks 3/27 Bkyi Litb Ytra Astc Ivr Ino Vxrt Codx Nvax Nnvc Ibio Htbx Mfa Nymt Corona Virus Dwt Inter Biglietti (rdmXrIpEZ6) - Fathom Journal

Best Stocks 3/27 Bkyi Litb Ytra Astc Ivr Ino Vxrt Codx Nvax Nnvc Ibio Htbx Mfa Nymt Corona Virus Dwt Inter Biglietti (rdmXrIpEZ6)  Fathom Journal

Best Stocks 3/27 Bkyi Litb Ytra Astc Ivr Ino Vxrt Codx Nvax Nnvc Ibio Htbx Mfa Nymt Corona Virus Dwt Inter Biglietti (rdmXrIpEZ6) - Fathom Journal

Click here to get full coverage on Vaxart to terminate headquarters lease early, plans relocation in South San Francisco - Investing.com

Vaxart to terminate headquarters lease early, plans relocation in South San Francisco  Investing.com

Vaxart to terminate headquarters lease early, plans relocation in South San Francisco - Investing.com

Click here to get full coverage on Best Stocks 3/27 Bkyi Litb Ytra Astc Ivr Ino Vxrt Codx Nvax Nnvc Ibio Htbx Mfa Nymt Corona Virus Dwt (DV2rpEtVWy) - Fathom Journal

Best Stocks 3/27 Bkyi Litb Ytra Astc Ivr Ino Vxrt Codx Nvax Nnvc Ibio Htbx Mfa Nymt Corona Virus Dwt (DV2rpEtVWy)  Fathom Journal

Best Stocks 3/27 Bkyi Litb Ytra Astc Ivr Ino Vxrt Codx Nvax Nnvc Ibio Htbx Mfa Nymt Corona Virus Dwt (DV2rpEtVWy) - Fathom Journal

Click here to get full coverage on Vaxart Appoints James Breitmeyer, M.D., Ph.D., to Board of Directors - Yahoo Finance

Vaxart Appoints James Breitmeyer, M.D., Ph.D., to Board of Directors  Yahoo Finance

Vaxart Appoints James Breitmeyer, M.D., Ph.D., to Board of Directors - Yahoo Finance

Click here to get full coverage on Vaxart (VXRT) Earnings Date and Reports 2026 $VXRT - MarketBeat

Vaxart (VXRT) Earnings Date and Reports 2026 $VXRT  MarketBeat

Vaxart (VXRT) Earnings Date and Reports 2026 $VXRT - MarketBeat

Click here to get full coverage on Vaxart to Host Upcoming Conference Calls - GlobeNewswire

Vaxart to Host Upcoming Conference Calls  GlobeNewswire

Vaxart to Host Upcoming Conference Calls - GlobeNewswire

Click here to get full coverage on Vaxart Provides Business Update and Reports Full Year 2025 Financial Results - GlobeNewswire

Vaxart Provides Business Update and Reports Full Year 2025 Financial Results  GlobeNewswire

Vaxart Provides Business Update and Reports Full Year 2025 Financial Results - GlobeNewswire

Click here to get full coverage on VXRT Forecast — Price Target — Prediction for 2027 - TradingView

VXRT Forecast — Price Target — Prediction for 2027  TradingView

VXRT Forecast — Price Target — Prediction for 2027 - TradingView

Click here to get full coverage on Vaxart to Host Second Quarter 2025 Business Update and Financial Results Conference Call on August 13 - GlobeNewswire

Vaxart to Host Second Quarter 2025 Business Update and Financial Results Conference Call on August 13  GlobeNewswire

Vaxart to Host Second Quarter 2025 Business Update and Financial Results Conference Call on August 13 - GlobeNewswire

Click here to get full coverage on Vaxart (VXRT) Stock Chart and Price History 2026 $VXRT - MarketBeat

Vaxart (VXRT) Stock Chart and Price History 2026 $VXRT  MarketBeat

Vaxart (VXRT) Stock Chart and Price History 2026 $VXRT - MarketBeat

Click here to get full coverage on VXRT SEC Filings - Vaxart Inc 10-K, 10-Q, 8-K Forms - Stock Titan

VXRT SEC Filings - Vaxart Inc 10-K, 10-Q, 8-K Forms  Stock Titan

VXRT

Price Chart

Key Statistics

Technicals

About VXRT

Latest News

Two new Vaxart directors urge support as group targets half the board - Stock Titan

Is Vaxart's (VXRT) Conference Spotlight Reframing the Oral Vaccine Story or Just Polishing It? - Yahoo Finance

Vaxart Inc (VXRT) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey

Advanced Charts

Top Gainers

Top Losers